Clinical studies recruiting near Macquarie University

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

HEAT Trial (HER2 Antibody Therapy With Lutetium-177)
EARLY_Phase 1 · Radiopharm Theranostics, Ltd · NCT06824155 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Macquarie University · Eli Lilly and Company · NCT07218380 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Macquarie University · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Macquarie University-MQ Health Clinical Trials Unit ( Site 2 · Merck Sharp & Dohme LLC · NCT06393374 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Pfizer · NCT06758401 Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/Phase 2 · Pfizer · NCT07421700 ROADMAP Clinical Trial
Phase 4 · University of Newcastle, Australia · NCT06771050 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Boehringer Ingelheim · NCT06531824 A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-0
Phase 3 · Macquarie University ( Site 2700) · Merck Sharp & Dohme LLC · NCT07489495 A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Phase 2 · Macquarie University ( Site 1801) · Merck Sharp & Dohme LLC · NCT06833073 Study of AVZO-021 in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · Macquarie University Hospital · Avenzo Therapeutics, Inc. · NCT05867251 IKS014 in Advanced Solid Tumors That Express HER2
Phase 1 · Iksuda Therapeutics Ltd. · NCT05872295 A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic P
Phase 1 · Genentech, Inc. · NCT05800665 A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HRS-3802 Monotherapy in Patients With Mal
Phase 1 · Shandong Suncadia Medicine Co., Ltd. · NCT06770569 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · AbbVie · NCT04928846 A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lu
Phase 2 · Johnson & Johnson Enterprise Innovation Inc. · NCT06667908 A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
Phase 1 · Macquarie University · Janssen Research & Development, LLC · NCT05818683 A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Phase 1 · Incyte Corporation · NCT07195916 Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors
Phase 1 · Telix Pharmaceuticals (Innovations) Pty Limited · NCT05868174 A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · CStone Pharmaceuticals · NCT06741644 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · Macquarie University ( Site 3010) · Merck Sharp & Dohme LLC · NCT03486873 A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in
Phase 3 · Nordic Lymphoma Group · NCT04332822 An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
NA · Pulmonx Corporation · NCT06035120 Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Phase 3 · Macquarie University-MQ Health Clinical Trials Unit ( Site 0 · Merck Sharp & Dohme LLC · NCT06136624 A Study of AP402 in HER2-Positive Patients With Locally or Advanced Solid Tumors
Phase 1/Phase 2 · AP Biosciences Inc. · NCT06669975 A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compar
Phase 3 · BeOne Medicines · NCT06943872 A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Parti
Phase 2 · Bayer · NCT06760819 A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Phase 1/Phase 2 · DualityBio Inc. · NCT05150691 A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours
Phase 1/Phase 2 · LaNova Medicines Limited · NCT06868199 A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Tr
Phase 3 · Macquarie University-MQ Health Clinical Trials Unit ( Site 2 · Merck Sharp & Dohme LLC · NCT06312176

Look up another city

Look up another condition